BioNexus Gene Lab Corp. (BGLC) stock analysis

Basic Materials · Specialty Chemicals

From the 10-K filed 2026-04-14

How it makes money

Industrial and medical customers pay for chemical raw materials and genomic screening services.

Industrial and medical customers pay for Chemrex's chemical raw materials and MRNA Scientific's genomic screening. Chemrex's sales volume drives the results of its chemical business.

What protects it: the moat

Management claims it has exclusive rights to the VitaGuard™ platform in the ASEAN region.

The VitaGuard™ platform uses artificial intelligence to monitor minimal residual disease, which is the detection of tiny amounts of cancer cells remaining after treatment.

What growth costs

It must reinvest in marketing and research to expand its commercial presence.

The company must invest in marketing to expand Chemrex, MRNA Scientific, and the VitaGuard™ platform. It also requires capital for research, development, and potential acquisitions.

What could damage it

Low market acceptance of its products could prevent it from generating enough revenue to survive.

Failure to gain market acceptance of its products leads to insufficient revenue, which prevents the company from sustaining its operations.

About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Other companies in Specialty Chemicals